Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Corcept Therapeutics Inc (NASDAQ:CORT)

8.00
Delayed Data
As of Dec 02
 +0.05 / +0.63%
Today’s Change
3.22
Today|||52-Week Range
10.00
+60.64%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues15.0M16.1M19.7M21.7M
 
 
 
 
 
Cost of Goods Sold336.0K376.0K402.0K647.0K
 
 
 
 
 
Depreciation And Amortization28.0K27.0K24.0K21.0K
 
 
 
 
 
 
Operating ExpensesGross Income14.6M15.7M19.3M21.1M
 
 
 
 
 
General Expenses13.0M15.1M17.8M18.0M
 
 
 
 
 
Research And Development4.1M4.6M5.7M7.1M
 
 
 
 
 
Total Operating Expenses13.3M15.5M18.2M18.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.7M592.0K1.5M3.1M
 
 
 
 
 
Interest Expense On Debt600.0K584.0K523.0K455.0K
 
 
 
 
 
Other Expenses-92.0K-27.0K-8.0K-32.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income959.0K-19.0K977.0K2.6M
 
 
 
 
 
Net Income959.0K-19.0K977.0K2.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS109.2M109.7M110.0M110.7M
 
 
 
 
 
Shares To Calculate EPS Diluted113.8M109.7M115.3M116.4M
 
 
 
 
 
 
Earnings Per ShareEPS$0.01$0.00$0.01$0.02
 
 
 
 
EPS Diluted$0.01-$0.00$0.01$0.02